Clinical Trials List
2025-08-01 - 2032-12-31
Phase III
Recruiting5
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 黃意方 無
- I-hung Shao 無
- Rita cheng 無
- Po-Jung Su Division of Hematology & Oncology
- See-Tong Pang 無
- Yung-Chang Lin 無
- Kung-Chu Ho 無
- PO-HUNG LIN 無
- Hong-Cheng Gan 無
- Jing-Ren Tseng Division of Nuclear Medicine
- 黃文冠 Division of Hematology & Oncology
- 沈鼎文 無
- Kai-Jie Yu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ying-Chun Shen 無
- 曾啟新 無
- PO-MING CHOW 無
- Yu-Chieh Tsai 無
- YU-CHUAN LU 無
- JIAN-HUA HONG 無
- 邱士庭 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張晉誠 無
- - - 無
- FU-JEN HSUEH 無
- 莊佩儒 無
- JEI-YIE HUANG 無
- 闕士傑 無
- 吳書丞 無
- CHUNG-HSIN CHEN 無
- Yeong-Shiau Pu 無
- 王中傑 無
- JHE-CYUAN GUO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
940 participants
